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WS13.1 Lung clearance index predicts time to pulmonary
exacerbation in children with CF
F. Vermeulen1, M. Boon1, M. Proesmans1, T. Havermans1, K. De Boeck1.
1University Hospital Leuven, Leuven, Belgium
Lung Clearance Index (LCI) is a promising endpoint for use in CF clinical trials.
Since correlation with validated clinical endpoints has not yet been established,
we investigated the association between baseline LCI and risk of respiratory tract
exacerbations (RTE) in children with CF.
Methods: During a prospective observational study, baseline LCI (N2 washout),
FEV1 and CFQR respiratory domain (CFQRres) were measured. RTE, deﬁned as
an increase in respiratory symptoms treated with IV antibiotics, were recorded
during one year. Whether basline LCI predicted RTE was assessed with a Poisson
regression model and Kaplan–Meier plots. LCI z-scores were calculated from values
in 57 healthy children.
Results: In 63 children with CF (median age 12.4 years, range 5−19), mean LCI
z-score was 5.3 (SD 4.6) and mean FEV1 z-score −0.9 (SD 1.3). CFQRres correlated
with LCI (R = −0.43, p< 0.001), but not with FEV1 (R=0.24, p = 0.051). In the
53 patients with a normal FEV1, CFQRres and LCI were still correlated (R = −0.44,
p = 0.002).
During the 12 months follow up, 25 patients (40%) experienced 47 RTE. LCI
and FEV1 were predictors of RTE. Time to ﬁrst RTE decreased with worsening
LCI quartiles (Log Rank test, p< 0.001). Similarly, compared to the quartile with
the lowest LCI, yearly RTE rate ratio in increasing LCI quartiles was 2.8 (95%CI
0.6–13.9, p = 0.205), 4.7 (95%CI 1.0–21.4, p = 0.046) and 13.6 (95%CI 3.2–57.0,
p< 0.001). In the group with normal FEV1, LCI but not FEV1 z-score was still a
predictor of RTE.
Conclusion: Baseline LCI predicts the risk of RTE in children with CF, even in
the subgroup with normal FEV1. These data further support the use of LCI as
surrogate outcome in CF clinical trials.
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Introduction: Persistent colonisation with Pseudomonas aeruginosa (PA) and
Staphylococcus aureus (SA) is associated with a decline in LCI in children.
Objective: To compare LCI in patients with; PA only Vs. PA plus another organism;
and SA only Vs. SA plus another organism.
Methods: Stable CF patients from adult & paediatric Northern Ireland CF centres
were recruited. LCI was derived from multiple breath washout, using 0.2%SF6 and a
modiﬁed Innocor™ device. All known pathogens present in sputum were recorded, as
analysed by routine diagnostic culture. Mann-Whitney U tests were used.
Results: n = 84; mean (SD) age 23.0 (13.1) range 6−65 yrs; M: 49; 32% F508del
homozygous (Table 1).
Table 1. Pathogens detected and LCI results
Pathogens detected n (%) Age (yrs),
mean (SD)
LCI, mean (SD),
range
FEV1
% predicted,
mean (SD)
PA only 24 (28.6) 27.8 (11.0) 11.5 (2.7) 6.6–16.8 67.8 (16.6)
PA plus other 11 (13.1) 20.0 (5.8) 10.2 (1.4) 8.0–12.6 78.5 (18.7)
SA only 14 (16.7) 17.9 (6.6) 8.5 (2.3) 5.4–13.6 78.5 (16.0)
SA plus other 9 (10.7) 22.0 (19.7) 8.9 (2.5) 6.2–13.1 81.3 (20.3)
No signiﬁcant growth 26 (31.0) 22.9 (15.9) 7.3 (0.9) 5.8−8.9 86.0 (17.7)
LCI was highest (worst) in the PA only group. There was no signiﬁcant difference in
LCI between PA only and PA plus other groups; or between SA only and SA plus other
groups. Compared to no signiﬁcant growth, LCI was signiﬁcantly higher in PA only
(p< 0.001) and PA plus other (p< 0.001) groups. There was a trend towards a higher
LCI in patients with SA only (p = 0.055) and SA plus other (p = 0.06).
Conclusions: In this study, another pathogenic organism in combination with PA or
SA did not result in a signiﬁcantly higher LCI. LCI detected differences and trends
between those groups with infection and those with no signiﬁcant growth.
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Aim: To assess the relative sensitivity of FEV1 and LCI in the detection of
improvement after IV treatment among CF children chronically colonized with
pseudomonas aeruginosa; to compare the effectiveness of IV treatment, when it’s
administered on a regular basis, or for acute exacerbations.
Methods: Thirty-two children, chronically colonized with pseudomonas aeruginosa,
were admitted to be given IV antibiotics for two weeks. Nineteen patients received
a course of elective treatment (group A) and 13 patients received IV antibiotic
regimens for an acute exacerbation (group B). Spirometry and multiple-breath-
washout tests were performed before and one month after IV antibiotic treatment.
Results: Thirty-two CF patients (15 males) were requited. The mean age at
admission was 9.90 years and the mean FEV1 % predicted was 83.43.
FEV1 did not change signiﬁcantly after iv treatment (p = 0.156). LCI decreased
by 15% (p = 0.0001). The mean LCI was changed signiﬁcantly by 6% (p = 0.018)
among patients of group A. On the contrary, spirometric parameters had no
statistically signiﬁcant changes in this group. Patients of group B showed signiﬁcant
improvement in most of the lung function parameters; mean LCI decreased by 26%
(p = 0.0001). FEV1% increased signiﬁcantly by 10.36% (p = 0.05). The mean LCI
difference was signiﬁcantly greater in group B compared to group A (p = 0.001).
Conclusions: LCI is a more sensitive index than FEV1 to assess the effectiveness
of IV antibiotic treatment among children with CF. Administration of IV antibiotic
regimens is more effective on ventilation distribution, when it is given for an
exacerbation in comparison to administration on a regular basis.
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The role of cCT scores in predicting a subsequent Pseudomonas aeruginosa (PsA)
colonization has not been investigated.
Objective: To demonstrate that cCT Brody score in CF children PsA free predicts
the risk of colonization in the following 6 years.
Methods: cCT scans performed in 80 pediatric CF patients between 2004 and
2007 in a single center were scored using the Brody II system. All patients were
then closely monitored with at least 4 sputum culture/year for a period of 6 years.
Chronic colonization by PsA was deﬁned as 3 or more positive sputum cultures
in one year. One-way ANOVA was used to determine mean’s differences in cCT
scores according to PsA status at baseline and after 6 years.
Results: Median age and mean FEV1% pred. at cCT were respectively 7.9 y and
83.3%. At baseline, 66.3% patients were PsA free, 23.7% had episodic PsA, 10%
had chronic PsA. Six years later, 13 of patients PsA free or episodically infected at
baseline became chronically colonized with PsA (group A) and 59 patients remained
PsA free or exhibited episodic infections (group B).
Children in group A had a signiﬁcantly worse CT score at baseline (Mean 19, SD
9.1) compared with patients in group B (Mean 10, SD 9.1), F = 12.1, p< 0.001.
Signiﬁcant differences between groups were found for bronchiectasis (Mean 20.6
vs 11.7; F 14.9, p< 0.001).
Conclusions: These results suggest that early lung structural damage precedes
chronic PsA infection in young children with cystic ﬁbrosis. cCT should be
performed early to identify patients at higher risk of PsA colonization.
